Ferrocene Aromatic Drug Derivative from China
Ferrocene-based aromatic metallocene used in anti-cancer drug development with iron-carbon sandwich structure. HTS 2931.90.22.00 covers this aromatic organo-inorganic pharmaceutical as metal is linked through carbon atoms.
Duty Rate — China → United States
31.5%
Rate breakdown
9903.88.0325%Except as provided in headings 9903.88.13, 9903.88.18, 9903.88.33, 9903.88.34, 9903.88.35, 9903.88.36, 9903.88.37, 9903.88.38, 9903.88.40, 9903.88.41, 9903.88.43, 9903.88.45, 9903.88.46, 9903.88.48, 9903.88.56, 9903.88.64, 9903.88.66, 9903.88.67, 9903.88.68, or 9903.88.69, articles the product of China, as provided for in U.S. note 20(e) to this subchapter and as provided for in the subheadings enumerated in U.S. note 20(f)
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Demonstrate therapeutic redox properties qualifying as drug via published pharmacology studies
• Use airtight secondary packaging for air-sensitive metallocenes during ocean transport
• Classify under proper HS code for EAR/ITAR if dual-use pharmaceutical technology